Cancer and Trojan Horse Therapy

Ian C. Langtree - Writer/Editor for Disabled World (DW)
Published: 2009/07/01 - Updated: 2010/04/15
Category Topic: Treatment of Cancer - Academic Publications

Page Content: Synopsis - Introduction - Main

Synopsis: An editorial presenting the Trojan Horse Therapy research being done in Australia related to Cancer.

Introduction

While browsing through the news as I do every morning, I ran across an article related to cancer research being performed by a group of Australians through Sydney-based EnGeneIC.

Main Content

The story pleased me very much because it presented research that has the potential to end the need for persons who are experiencing different forms of cancer to ever endure chemotherapy again. If the research this group is pursuing succeeds in human trials in Melbourne hospitals this year, the reduction in human suffering could be historic.

Understand that towards the end of last year and into the early part of this year I had spend a good deal of time writing about the various Ribbon Campaigns associated with different forms of cancer. Here in Colorado Springs alone there are many people who have cancer from exposure to the sun. It is difficult for me to attempt to imagine the numbers of people around the world who could benefit from the research being done by this group in Australia.

The research the Australian group is doing involves the use of a, 'Trojan Horse,' approach to treating cancer. What this means is that they are using tiny nano-cells which can be used to deliver anti-cancer medications directly to cancer cells, without affecting healthy cells that surround the cancerous ones. Chemotherapy, on the other hand, damages whatever it comes in contact with. The nano-cells this group is using have been improved by this group of researchers, to the point where they are claiming a one-hundred percent efficiency rate at treatment of cancer in the mice they are using in their research.

The mice they have been using are resistant to conventional chemotherapy. The significance of this statement alone is profound. People with difficult to treat forms of cancer can only witness this research and pray that the human trials go extremely well. The research and work that this group of people are performing gives people with cancer hope.

The nano cells being used are administered in what is being described as, 'waves,' the first of which disable the cancer cells, removing the cancer cells' resistance mechanisms. The group has found that cancer cells are receptive to this form of treatment. Researchers have been able to use these nano cells repeatedly, loading them with a variety of different medications in order to fight cancer cells.

The best part of all of this is that should their research succeed in human trials - not only will chemotherapy become outdated, people with cancer will be able to receive this new form of therapy on an outpatient basis. The good news doesn't end there; this form of treatment uses less medication, and therefore presents less side-effects than chemotherapy as well. People would be able to receive treatment for cancer in a short period of time and go about their lives.


Author Credentials: Ian is the founder and Editor-in-Chief of Disabled World, a leading resource for news and information on disability issues. With a global perspective shaped by years of travel and lived experience, Ian is a committed proponent of the Social Model of Disability-a transformative framework developed by disabled activists in the 1970s that emphasizes dismantling societal barriers rather than focusing solely on individual impairments. His work reflects a deep commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his full biography.

Explore Similar Topics

: An in-depth look at CAR-T cell therapy, a personalized cancer treatment offering targeted, long-term immune response for hard-to-treat blood cancers.

: A team of scientists have taken a significant leap forward by developing a label-free SERS-Artificial intelligence method for cancer screening (SERS-AICS).

: Overexpression of certain genes pointed researchers to a vulnerability that might be exploited to target cancers with aneuploidy.

▶ Share Page

Citing and References

- APA | MLA | Chicago | Permalink

APA: Disabled World. (2009, July 1 - Last revised: 2010, April 15). Cancer and Trojan Horse Therapy. Disabled World (DW). Retrieved November 15, 2025 from www.disabled-world.com/health/cancer/treatment/trojan-horse-therapy.php

MLA: Disabled World. "Cancer and Trojan Horse Therapy." Disabled World (DW), 1 Jul. 2009, revised 15 Apr. 2010. Web. 15 Nov. 2025. <www.disabled-world.com/health/cancer/treatment/trojan-horse-therapy.php>.

Chicago: Disabled World. "Cancer and Trojan Horse Therapy." Disabled World (DW). Last modified April 15, 2010. www.disabled-world.com/health/cancer/treatment/trojan-horse-therapy.php.

Permalink: <a href="https://www.disabled-world.com/health/cancer/treatment/trojan-horse-therapy.php">Cancer and Trojan Horse Therapy</a>: An editorial presenting the Trojan Horse Therapy research being done in Australia related to Cancer.

While we strive to provide accurate, up-to-date information, our content is for general informational purposes only. Please consult qualified professionals for advice specific to your situation.